Implantable Collamer Lens Market to Grow at 13.1% CAGR through 2032 Amid Growing Prevalence of Myopia and Astigmatism - Future Market Insights, Inc.

The United States will continue dominating the North America implantable collamer lens market through 2032. Demand for implantable collamer lens in Europe is expected to register a growth of 16.2% over the next ten years.

NEWARK, Del., July 12, 2022 /PRNewswire/ -- As per Future Market Insights' latest industry analysis, the valuation for the global implantable collamer lens market was around US$ 212.9 Mn in 2021. Sales are projected to grow at a 13.1% CAGR over the forecast period, with the market valuation reaching US$ 838.2 Mn in 2032.

Since phakic intraocular implants were approved two decades ago, refractive surgeons have chosen to utilize them to treat myopia that is unresponsive to excimer laser treatment. A posterior chamber phakic intraocular lens (IOL) created and produced by STAAR Surgical, the Visian Implantable Collamer Lens (ICL), was FDA approved in 2005 and has been demonstrated to be effective in the correction of myopia up to 18.00 D.

The ICL was only offered in the U.S. in a spherical variant until 2018. As a result, high astigmatism and high myopia could not be treated simultaneously. In light of this, several surgeons in the refractive fiend adopted a sequential operation strategy that employs the use of an excimer-laser enhancement after ICL implantation. This sequence has been referred to as "Bioptics".

Get Sample PDF Of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15174

The use of ICL in refractive surgery is increasing. ICLs are often regarded as an alternative to laser-based corneal procedures such as LASIK and photorefractive keratectomy (PRK). The implantable collamer lens is a specific type of posterior chamber phakic intraocular lens (pIOL). High levels of refractive error or situations where corneal refractive surgery is not recommended call for the adoption of pIOL. Quicker healing and reversibility are the additional benefits of this procedure over corneal refractive surgery.

High incidence of cataracts and other vision impairments among elderly and diabetic individuals is underpinning the need for implantable collamer lens. In addition to this, rising healthcare costs, and government-backed investments for the construction of healthcare infrastructure are some of the key factors propelling the market.

"Growing prevalence of refractive disorders, and the emergence of alternatives to laser techniques for refractive correction are underpinning the demand for implantable collamer lens," says an FMI analyst.

Key Takeaways:

• By indication, sales in the myopia segment are slated to increase at a 12.6% CAGR through 2032.
• In terms of end user, demand in the hospitals segment will grow at a 11.7% CAGR during the forecast period.
• China accounted for 46.6% of the total market share in 2021 and the trend is expected to continue over the assessment period.
• The U.S. will continue dominating the North America implantable collamer lens market through 2032.
• Japan will emerge as a lucrative pocket in the East Asia implantable collamer lens market.

Browse Detailed Summary of Research Report with TOC @ https://www.futuremarketinsights.com/reports/implantable-collamer-lens-market

Competition Landscape

The global implantable collamer lens market includes only one manufacturer known as STAR SURGICAL. Incorporated in 1982 for the purpose of developing, producing, and marketing implantable lenses, the company is the first to receive the U.S. FDA approval for implantable collamer lens. Some recent developments include: 

• In April 2021, STAAR submitted clinical data to the FDA to support a marketing approval for their EVO family of myopia lenses. The submission remains under interactive review with the FDA.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the implantable collamer lens market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the indication (myopia, hyperopia, and astigmatism), and end user (hospitals, ophthalmic clinics, ambulatory surgical centers, and eye research institutes), across seven key regions.

Key Market Segments Covered in Implantable Collamer Lens Industry Research

By Indication:

• Myopia
• Hyperopia
• Astigmatism

By End User:

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers
• Eye Research Institutes

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• MEA

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15174

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here. 

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions & Exclusions

3. Key Market Trends

    3.1. Demand Side Trends

    3.2. Supply Side Trends

4. Key Success Factors

    4.1. Disease Epidemiology, by Region

    4.2. Product and Technology Assessment

    4.3. Regulatory Landscape

    4.4. Reimbursement Scenario

    4.5. Rise in Demand for Implantable Collamer Lenses

    4.6. PESTEL Analysis

    4.7. Porter's Analysis

Speak To Our Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-15174

Have a Look at Related Research Reports:

Organ Transport Devices Market: The global organ transport devices market is set to reach a valuation of US$ 115.1 Mn in 2022 and expand at a CAGR of 8.7% in the forecast period (2022-2032). The global market is projected to reach US$ 265.1 Mn by the end of 2032.

Hybrid Grafts Market: The global hybrid grafts market is expected to reach a valuation of US$ 517.3 Mn by the end of 2022, and further expand at a CAGR of 5.20% in 2022-2032. As per the report, the market is likely to reach a valuation of ~US$ 858.7 Mn by the end of 2032.

Peptide Receptor Radionuclide Therapy (PRRT) Market: The market is likely to record a strong CAGR of 7.2% during the forecast period. The market is currently valued at US$ 552.08 Mn in 2022 and is likely to reach US$ 1,106.50 Mn by 2032.

Late Stage Chronic Kidney Disease Therapeutics Market: The global demand for late stage chronic kidney disease therapeutics was valued at around US$ 4.7 Billion in 2019.

Motion Preservation Devices Market: The global motion preservation devices market is forecasted to be valued at US$ 3.0 million by 2032, up from US$ 1.7 million in 2022, advancing at a CAGR of 5.3% during the forecast period.

Smart Contact Lens Market Size - The smart contact lens contains a wireless chip and miniaturized sensor for monitoring of physiological parameters such as glucose levels in tears of a diabetic patient or intraocular pressure in glaucoma patients

Contact Lenses Market Share - The contact lenses market is estimated at USD 9.1 billion in 2022 and is projected to reach USD 12.5 billion by 2029

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com 
Website: https://www.futuremarketinsights.com  
Report: https://www.futuremarketinsights.com/reports/implantable-collamer-lens-market
LinkedIn | Twitter | Blogs

Logo: https://mma.prnewswire.com/media/1197648/FMI_Logo.jpg